Online citations, reference lists, and bibliographies.
← Back to Search

Apolipoprotein E And Alzheimer Disease: An Update On Genetic And Functional Analyses

A. Saunders
Published 2000 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Exceptional advances have been made in understanding the genetics of how common polymorphisms of the apolipoprotein E gene influence the risk and age of onset of Alzheimer disease (AD). The major genetic susceptibility locus for the common forms of AD, there are 3 common alleles, designated ε2, ε3, and ε4. The inheritance of each dose of APOE4 increases the risk of disease and decreases the age of onset; conversely, the APOE2 allele appears to be protective, by lowering the risk of disease and increasing the age of onset. Testing for the APOE4 allele can be a clinically useful tool in the early diagnosis of cognitively impaired patients suspected of having AD. The APOE4 allele also negatively influences functional recovery following a variety of brain insults. What remains in the study of apolipoprotein E is an explanation of how minor changes in a protein can produce such striking differences in risk and age of onset. In vitro and animal model studies strongly suggest that brain apolipoprotein E is a multifunctional molecule, with potential roles in amyloid deposition and clearance, microtubule stability, intracellular signaling, immune modulation, glucose metabolism, oxidative stress, and other cellular processes. While the relevance of these proposed functions to the etiology of AD remains a mystery, these and other hypotheses will be tested as the field of apoE neurobiology grows, adding relevant new data to the functions of apoE in health and in the pathogenic mechanisms leading to AD.
This paper references
Cerebrospinal Fluid Proteins Studied by Two‐Dimensional Gel Electrophoresis and Immunoblotting Technique
F. Wiederkehr (1987)
Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques
R. Katzman (1988)
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
M. Linton (1991)
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
Y. Namba (1991)
Molecular genetics of Alzheimer's disease.
S. Sorbi (1993)
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
W. Strittmatter (1993)
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
D. Schmechel (1993)
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E. Corder (1993)
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
A. M. Saunders (1993)
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
W. Strittmatter (1993)
Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).
M. Krieger (1994)
Alzheimer's disease and possible gene interaction.
P. St George-Hyslop (1994)
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
C. Harrington (1994)
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.
W. Strittmatter (1994)
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
E. Corder (1994)
Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.
C. Berr (1994)
NHLBI funding policies. Enhancing stability, predictability, and cost control.
C. Lenfant (1994)
Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease
David Y. Huang (1994)
The apolipoprotein E allele epsi;4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease
D. Galasko (1994)
Isoform-specific binding of apolipoprotein E to beta-amyloid.
M. LaDu (1994)
Structures and Functions of Multiligand and Lipoprotein Receptors
M. Krieger (1994)
Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease.
D. Rubinsztein (1994)
Apolipoprotein E: structure-function relationships.
K. Weisgraber (1994)
Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.
M. C. Chartier-Harlin (1994)
Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease
C. Duijn (1994)
Apolipoprotein E: Structure–function relationship
KH Weisgraber (1994)
Apolipoprotein E allele frequency in patients with cognitive defects following cardiopulmonary bypass
B Tardiff (1994)
Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptorrelated protein (LRP)
M Krieger (1994)
Structure–function relationship
Kh Weisgraber (1994)
On the metabolism of apolipoprotein E and the Alzheimer diseases
A. Roses (1995)
Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury
J. Nicoll (1995)
Alzheimer's disease with and without coexisting Parkinson's disease changes
M. Gearing (1995)
Regional Variation in the Distribution of Apolipoprotein E and Aβ in Alzheimer's Disease
Marla Gearing (1995)
ApoE as a prognostic factor for post–traumatic coma
S. Sorbi (1995)
The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*)
B. Nathan (1995)
Head injury, amyloid β and Alzheimer's disease
A. Roses (1995)
ApoE genotype and survival from intracerebral haemorrhage
M. Alberts (1995)
Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E.
L. Mercken (1995)
Phosphorylation of tau in apolipoprotein E-deficient mice
I. Genis (1995)
Apolipoprotein E genotyping in the diagnosis of alzheimer's disease
M. Ilyas kamboh (1995)
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
G. Small (1995)
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
C. Hulette (1995)
Neurodegeneration in the Central Nervous System of apoE-Deficient Mice
E. Masliah (1995)
Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.
J. Nicoll (1995)
Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease
R. Mayeux (1995)
ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation
David Y. Huang (1995)
Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease
E. Corder (1995)
Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease
A. Roses (1995)
Apolipoprotein E genotyping in differential diagnosis, not prediction, of Alzheimer’s disease (Point of View)
AD Roses (1995)
genotyping in differential diagnosis , not prediction , of Alzheimer ’ s disease ( Point of View )
AD Roses (1995)
Measuring the genetic contribution of APOE in late-onset Alzheimer diease
AD Roses (1995)
Apolipoprotein E genotyping in differential diagnosis, not prediction, of Alzheimer's disease (Point of View)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.
I. McKeith (1996)
Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease
M. Gearing (1996)
The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.
A. Golabek (1996)
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
E. Reiman (1996)
Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease
B. Kakulas (1996)
Differential Binding of Apolipoprotein E Isoforms to Tau and Other Cytoskeletal Proteins
L. Fleming (1996)
The Interaction between Apolipoprotein E and Alzheimers Amyloid -Peptide Is Dependent on -Peptide Conformation (*)
A. Golabek (1996)
Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease
A. Saunders (1996)
Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta.
W. Chan (1996)
Specificity, sensitivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer disease
AM Saunders (1996)
A beta-peptide length and apolipoprotein E genotype in Alzheimer’s disease
M Gearing (1996)
Apoliprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's disease (CER- AD)
Ka Welsh-Bohmer (1996)
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
L. Farrer (1997)
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease
L. Farrer (1997)
Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein.
C. Haas (1997)
Further characterization of a monoclonal antibody recognizing apolipoprotein E peptides in amyloid deposits.
T. Yamada (1997)
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.
K. Bales (1997)
Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing.
B. Jordan (1997)
Severe learning deficits in apolipoprotein E-knockout mice in a water maze task
M. Oitzl (1997)
Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE
E. Masliah (1997)
Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease
Y. Aizawa (1997)
Apolipoprotein E genotypes in a neuropathological series from the consortium to establish a registry for Alzheimer's disease
K. Welsh-Bohmer (1997)
Apolipoprotein-E deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice
Y. Zhou (1998)
ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.
H. Houlden (1998)
Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.
M. McNamara (1998)
Apolipoprotein E Genotype and Deposits of Aβ40 and Aβ42 in Alzheimer Disease
M. McNamara (1998)
Molecular genetics of Alzheimer's disease.
M. Cruts (1998)
Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau.
M. Spillantini (1998)
Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse
R. Anderson (1998)
Human apolipoprotein E accelerates microtubule polymerization in vitro
B. Scott (1998)
Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways
X. Wang (1998)
Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N141I)
D. Nochlin (1998)
Nascent Astrocyte Particles Differ from Lipoproteins in CSF
M. LaDu (1998)
Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
S. Craft (1998)
Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease
S. Craft (1998)
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.
R. Mayeux (1998)
Specific regional transcription of apolipoprotein E in human brain neurons.
P. Xu (1999)
Direct Binding of Reelin to VLDL Receptor and ApoE Receptor 2 Induces Tyrosine Phosphorylation of Disabled-1 and Modulates Tau Phosphorylation
T. Hiesberger (1999)
Reelin Is a Ligand for Lipoprotein Receptors
G. D’Arcangelo (1999)
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.
D. Holtzman (1999)
Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.
R. Mahley (1999)
Neuronal cytoskeletal changes are an early consequence of repetitive head injury
J. F. Geddes (1999)
J Neuropathol Exp Neurol
Genetic And (2000)
J Neuropathol Exp Neurol

This paper is referenced by
APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
M. Husain (2021)
Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology
Jing Wang (2021)
Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer’s disease
Jaeho Kim (2021)
Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer’s Disease
M. Oyarzún (2021)
Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias
Sadat Shafi (2021)
Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
D. Kaur (2021)
Cell type-specific histone acetylation profiling of Alzheimer’s Disease subjects and integration with genetics
Easwaran Ramamurthy (2020)
Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease
D. Butterfield (2020)
The Genetics of Alzheimer’s Disease in the Chinese Population
Chen-Ling Gan (2020)
Presence of the apolipoprotein E-ε4 allele is associated with an increased risk of sepsis progression
Y. Shao (2020)
Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition
S. Burnham (2020)
Genetic factors related to the immune system in subjects at risk of developing Alzheimer's disease.
Michał Prendecki (2020)
Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease.
H. Kasahara (2019)
Genetic Markers of Alzheimer's Disease.
M. Nikolac Perkovic (2020)
Conformational analysis of apolipoprotein E3/E4 heteromerization
K. Tu (2019)
Role of APOE and IL18RAP gene polymorphisms in cervical spondylotic myelopathy in Indian population
S. Diptiranjan (2019)
Impacts of apolipoprotein E disclosure on healthy Asian older adults: a cohort study
Wei Theng Sng (2019)
Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease
T. Voss (2018)
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
G. Femminella (2017)
4.16 – Aging and Alzheimer's Disease
S. Sindi (2017)
Genetic, Biochemical and Cellular Correlates Associated with Alzheimer’s Disease
P. Jairani (2016)
The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
Luise Christine Löwe (2016)
Cognitive Function, APOE Gene Polymorphisms, and Thyroid Status Associations in Postmenopausal Women in Poland
I. Bojar (2016)
Genes associated with Alzheimer’s disease: an overview and current status
Mohan Giri (2016)
Alzheimer's Disease: Pathophysiology, Hypotheses and Treatment Strategies
Azza A. Ali (2016)
Neuroinflammation and Alteration of the Blood-Brain Barrier in Alzheimer´s Disease
Luis O Soto-Rojas (2015)
Influence of Amyloid-&bgr; on Cognitive Decline After Stroke/Transient Ischemic Attack: Three-Year Longitudinal Study
Wenyan Liu (2015)
Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer's Disease.
S. Oleson (2015)
Neuronal response in Alzheimer’s and Parkinson’s disease: the effect of toxic proteins on intracellular pathways
S. Majd (2015)
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
Sagar H. Barage (2015)
Predicative genetic testing for Alzheimer's disease.
Tih-Shih Lee (2014)
Different Adenosine A 2 A Receptor Expression in Peripheral Cells from Elderly Patients with Vascular Dementia and Alzheimer ’ s Disease
Cristina Gussagoa (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar